A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review and Case Challenges Illustrating Current Therapeutic Standards

Review the latest evidence-based strategies for contemporary myelofibrosis care with an on-demand webcast, downloadable slides from a live presentation series, and an expert commentary.

Share

Program Content

Activities

Myelofibrosis Care
A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review Illustrating Current Therapeutic Standards
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2023

Expires: February 27, 2024

Activities

Myelofibrosis Care
A Community Practitioner’s Guide to Contemporary Myelofibrosis Care: Data Review and Case Challenges Illustrating Current Therapeutic Standards
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2023

Expires: June 14, 2024

Activities

Contemporary Myelofibrosis Care
Contemporary Myelofibrosis Care: Experts Answer Your Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 18, 2023

Faculty

cover img faculity

Raajit K. Rampal, MD, PhD

Associate Member
Director, MPN and Rare Hematologic Malignancies Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Prithviraj Bose, MD

Professor
Department of Leukemia
UT MD Anderson Cancer Center
Houston, Texas

cover img faculity

Stephen Oh, MD, PhD

Associate Professor of Medicine
Co-Chief, Division of Hematology
Washington University School of Medicine
St Louis, Missouri

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from

CTI BioPharma Corp

GSK

Incyte Corporation